Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-023998

Director acquired 40,258 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Autor Deborah M. Director 2025-05-05 Option exercise +40,258 93,660 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Autor Deborah M. Director 2025-05-05 Option exercise · Restricted Stock Units −40,258 0 D: show line 2 in the form
Autor Deborah M. Director 2025-05-06 Grant or award · Restricted Stock Units +34,819 34,819 D: show line 3 in the form
Loading xslF345X05/wk-form4_1746745819.xml…